These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34244970)

  • 1. Psychometric Analysis from EMBODY1 and 2 Clinical Trials to Help Select Suitable Fatigue PRO Scales for Future Systemic Lupus Erythematosus Studies.
    Cleanthous S; Bongardt S; Marquis P; Stach C; Cano S; Morel T
    Rheumatol Ther; 2021 Sep; 8(3):1287-1301. PubMed ID: 34244970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN).
    Williams-Hall R; Berry P; Williamson N; Barclay M; Roberts A; Gater A; Tolley C; Bradley H; Ward A; Hsia E; Zuraw Q; DeLong P; Touma Z; Strand V
    Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 36007978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76).
    Rendas-Baum R; Baranwal N; Joshi AV; Park J; Kosinski M
    J Patient Rep Outcomes; 2021 Apr; 5(1):33. PubMed ID: 33830377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review.
    Strand V; Simon LS; Meara AS; Touma Z
    Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32591423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.
    Holloway L; Humphrey L; Heron L; Pilling C; Kitchen H; Højbjerre L; Strandberg-Larsen M; Hansen BB
    Health Qual Life Outcomes; 2014 Jul; 12():116. PubMed ID: 25048687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-Related Quality of Life Improvements in Systemic Lupus Erythematosus Derived from a Digital Therapeutic Plus Tele-Health Coaching Intervention: Randomized Controlled Pilot Trial.
    Khan F; Granville N; Malkani R; Chathampally Y
    J Med Internet Res; 2020 Oct; 22(10):e23868. PubMed ID: 33079070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical meaningfulness of a British Isles Lupus Assessment Group-based Composite Lupus Assessment response in terms of patient-reported outcomes in moderate to severe systemic lupus erythematosus: a post-hoc analysis of the phase 3 TULIP-1 and TULIP-2 trials of anifrolumab.
    Strand V; O'Quinn S; Furie RA; Morand EF; Kalunian KC; Schwetje EG; Abreu G; Tummala R
    Lancet Rheumatol; 2022 Mar; 4(3):e198-e207. PubMed ID: 38288936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus.
    Morel T; Cano S; Bartlett SJ; Gordon C; Haier B; Regnault A; Schneider M; Stach C; Cleanthous S
    Rheumatology (Oxford); 2022 Aug; 61(8):3329-3340. PubMed ID: 34897375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capturing the patient experience in systemic lupus erythematosus: Are widely used measures fit-for-purpose and adherent to FDA PRO guidance recommendations?
    Majercak KR; Perfetto EM; Villalonga-Olives E
    J Patient Rep Outcomes; 2022 Jan; 6(1):7. PubMed ID: 35061149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meaningful score changes for SF-36v2, FACIT-fatigue, and RASIQ in rheumatoid arthritis.
    Rendas-Baum R; Lin X; Kosinski M; Bjorner JB; Bracher MG; Chen WH
    J Patient Rep Outcomes; 2024 Jan; 8(1):9. PubMed ID: 38252223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
    Conti F; Perricone C; Reboldi G; Gawlicki M; Bartosiewicz I; Pacucci VA; Massaro L; Miranda F; Truglia S; Alessandri C; Spinelli FR; Teh LS; Ceccarelli F; Valesini G
    Lupus; 2014 Jul; 23(8):743-51. PubMed ID: 24569393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE.
    Devilliers H; Amoura Z; Besancenot JF; Bonnotte B; Pasquali JL; Wahl D; Maurier F; Kaminsky P; Pennaforte JL; Magy-Bertrand N; Arnaud L; Binquet C; Guillemin F; Bonithon-Kopp C
    Rheumatology (Oxford); 2015 May; 54(5):940-9. PubMed ID: 25361539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus.
    Azizoddin DR; Weinberg S; Gandhi N; Arora S; Block JA; Sequeira W; Jolly M
    Lupus; 2018 Apr; 27(5):728-737. PubMed ID: 29087259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL).
    Ahmad Pouzi NA; Shaharir SS; Mohd Tamil A; Mustafar R; Ahmad Maulana S; Mageswaren E; Wan Ghazali WS
    PLoS One; 2023; 18(5):e0285461. PubMed ID: 37186611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of fatigue severity scale in Chinese systemic lupus erythematosus patients.
    Feng C; He Q; Wu Y; Hu X; Wu J; He X; Zhao S
    Health Qual Life Outcomes; 2019 Apr; 17(1):71. PubMed ID: 31014340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue in Parkinson's disease: measurement properties of a generic and a condition-specific rating scale.
    Nilsson MH; Bladh S; Hagell P
    J Pain Symptom Manage; 2013 Nov; 46(5):737-46. PubMed ID: 23507131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials.
    Bartlett SJ; Bingham CO; van Vollenhoven R; Murray C; Gruben D; Gold DA; Cella D
    Arthritis Res Ther; 2022 Apr; 24(1):83. PubMed ID: 35382883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.
    Elefante E; Tani C; Stagnaro C; Ferro F; Parma A; Carli L; Signorini V; Zucchi D; Peta U; Santoni A; Raffaelli L; Mosca M
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32075876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue in systemic lupus: the role of disease activity and its correlates.
    Azizoddin DR; Gandhi N; Weinberg S; Sengupta M; Nicassio PM; Jolly M
    Lupus; 2019 Feb; 28(2):163-173. PubMed ID: 30580659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative validation of the FACIT-fatigue scale in systemic lupus erythematosus.
    Kosinski M; Gajria K; Fernandes AW; Cella D
    Lupus; 2013 Apr; 22(5):422-30. PubMed ID: 23423250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.